CAI Caris Life Sciences, Inc.
Healthcare$15.55-2.45%ClosedMarket Cap: $4.40B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$28.60
Target (Median)
$30.00
Target Range
$21.00 - $38.00
Upside from current price: 83.9%
Rating Distribution
1 Strong Buy10 Buy2 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-08 | JP Morgan | maintain | Overweight | Overweight |
| 2026-05-08 | Citigroup | maintain | Buy | Buy |
| 2026-05-08 | BTIG | maintain | Buy | Buy |
| 2026-04-06 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2026-03-13 | Canaccord Genuity | maintain | Hold | Hold |
| 2026-02-27 | Baird | maintain | Outperform | Outperform |
| 2026-02-27 | BTIG | maintain | Buy | Buy |
| 2026-02-27 | Evercore ISI Group | maintain | Outperform | Outperform |
| 2025-12-22 | Canaccord Genuity | maintain | Hold | Hold |
| 2025-08-13 | Guggenheim | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $0.37 | $1.21B | 8 |
| Sun Dec 31 | $0.61 | $1.41B | 7 |
| Mon Dec 31 | $0.91 | $1.63B | 2 |
| Tue Dec 31 | $1.17 | $1.84B | 5 |